{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T19:56:20Z","timestamp":1771530980226,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1124\/jpet.104.079079","type":"journal-article","created":{"date-parts":[[2005,3,18]],"date-time":"2005-03-18T04:45:17Z","timestamp":1111121117000},"page":"64-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Effects of Prostaglandin D2, 15-Deoxy-\u039412,14-prostaglandin J2, and Selective DP1 and DP2 Receptor Agonists on Pulmonary Infiltration of Eosinophils in Brown Norway Rats"],"prefix":"10.1016","volume":"313","author":[{"given":"Wagdi","family":"Almishri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Cossette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Rokach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qutayba","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William S.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.104.079079_bib1","doi-asserted-by":"crossref","unstructured":"Arimura A, Yasui K, Kishino J, Asanuma F, Hasegawa H, Kakudo S, Ohtani M, and Arita H (2001) Prevention of allergic inflammation by a novel prostaglandin receptor antagonist, S-5751. J Pharmacol Exp Ther 298: 411\u2013419.","DOI":"10.1016\/S0022-3565(24)29398-8"},{"key":"10.1124\/jpet.104.079079_bib2","doi-asserted-by":"crossref","unstructured":"Bell-Parikh LC, Ide T, Lawson JA, McNamara P, Reilly M, and FitzGerald GA (2003) Biosynthesis of 15-deoxy-\u039412,14-PGJ2 and the ligation of PPAR\u03b3. J Clin Investig 112: 945\u2013955.","DOI":"10.1172\/JCI200318012"},{"key":"10.1124\/jpet.104.079079_bib3","doi-asserted-by":"crossref","unstructured":"Brink C, Dahlen SE, Drazen J, Evans JF, Hay DW, Rovati GE, Serhan CN, Shimizu T, and Yokomizo T (2004) International Union of Pharmacology XLIV. Nomenclature for the oxoeicosanoid receptor. Pharmacol Rev 56: 149\u2013157.","DOI":"10.1124\/pr.56.1.4"},{"key":"10.1124\/jpet.104.079079_bib4","doi-asserted-by":"crossref","unstructured":"Coleman RA and Sheldrick RL (1989) Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP-receptors. Br J Pharmacol 96: 688\u2013692.","DOI":"10.1111\/j.1476-5381.1989.tb11869.x"},{"key":"10.1124\/jpet.104.079079_bib5","doi-asserted-by":"crossref","unstructured":"Cuzzocrea S, Wayman NS, Mazzon E, Dugo L, Di Paola R, Serraino I, Britti D, Chatterjee PK, Caputi AP, and Thiemermann C (2002) The cyclopentenone prostaglandin 15-deoxy-\u039412,14-prostaglandin J2 attenuates the development of acute and chronic inflammation. Mol Pharmacol 61: 997\u20131007.","DOI":"10.1016\/S0026-895X(24)12195-5"},{"key":"10.1124\/jpet.104.079079_bib6","doi-asserted-by":"crossref","unstructured":"Emery DL, Djokic TD, Graf PD, and Nadel JA (1989) Prostaglandin D2 causes accumulation of eosinophils in the lumen of the dog trachea. J Appl Physiol 67: 959\u2013962.","DOI":"10.1152\/jappl.1989.67.3.959"},{"key":"10.1124\/jpet.104.079079_bib7","doi-asserted-by":"crossref","unstructured":"Fitzpatrick FA and Wynalda MA (1983) Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. J Biol Chem 258: 11713\u201311718.","DOI":"10.1016\/S0021-9258(17)44287-6"},{"key":"10.1124\/jpet.104.079079_bib8","doi-asserted-by":"crossref","unstructured":"Flower RJ, Harvey EA, and Kingston WP (1976) Inflammatory effects of prostaglandin D2 in rat and human skin. Br J Pharmacol 56: 229\u2013233.","DOI":"10.1111\/j.1476-5381.1976.tb07446.x"},{"key":"10.1124\/jpet.104.079079_bib9","doi-asserted-by":"crossref","unstructured":"Frew AJ and Kay AB (1988) The relationship between infiltrating CD4+ lymphocytes, activated eosinophils and the magnitude of the allergen-induced late phase cutaneous reaction in man. J Immunol 141: 4158\u20134164.","DOI":"10.4049\/jimmunol.141.12.4158"},{"key":"10.1124\/jpet.104.079079_bib10","doi-asserted-by":"crossref","unstructured":"Fujitani Y, Kanaoka Y, Aritake K, Uodome N, Okazaki-Hatake K, and Urade Y (2002) Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. J Immunol 168: 443\u2013449.","DOI":"10.4049\/jimmunol.168.1.443"},{"key":"10.1124\/jpet.104.079079_bib11","doi-asserted-by":"crossref","unstructured":"Gervais FG, Cruz RP, Chateauneuf A, Gale S, Sawyer N, Nantel F, Metters KM, and O\u2019Neill GP (2001) Selective modulation of chemokinesis, degranulation and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. J Allergy Clin Immunol 108: 982\u2013988.","DOI":"10.1067\/mai.2001.119919"},{"key":"10.1124\/jpet.104.079079_bib12","doi-asserted-by":"crossref","unstructured":"Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, and Willoughby DA (1999) Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5: 698\u2013701.","DOI":"10.1038\/9550"},{"key":"10.1124\/jpet.104.079079_bib13","doi-asserted-by":"crossref","unstructured":"Hammad H, de Heer HJ, Soullie T, Hoogsteden HC, Trottein F, and Lambrecht BN (2003) Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1. J Immunol 171: 3936\u20133940.","DOI":"10.4049\/jimmunol.171.8.3936"},{"key":"10.1124\/jpet.104.079079_bib14","doi-asserted-by":"crossref","unstructured":"Heinemann A, Schuligoi R, Sabroe I, Hartnell A, and Peskar BA (2003) \u039412-Prostaglandin J2, a plasma metabolite of prostaglandin D, causes eosinophil mobilization from the bone marrow and primes eosinophils for 2chemotaxis. J Immunol 170: 4752\u20134758.","DOI":"10.4049\/jimmunol.170.9.4752"},{"key":"10.1124\/jpet.104.079079_bib15","doi-asserted-by":"crossref","unstructured":"Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, Ichimasa M, Sugamura K, Nakamura M, Takano S, et al. (2001) Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils and basophils via seven-transmembrane receptor CRTH2. J Exp Med 193: 255\u2013261.","DOI":"10.1084\/jem.193.2.255"},{"key":"10.1124\/jpet.104.079079_bib16","doi-asserted-by":"crossref","unstructured":"Honda K, Arima M, Cheng G, Taki S, Hirata H, Eda F, Fukushima F, Yamaguchi B, Hatano M, Tokuhisa T, et al. (2003) Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine. J Exp Med 198: 533\u2013543.","DOI":"10.1084\/jem.20022218"},{"key":"10.1124\/jpet.104.079079_bib17","doi-asserted-by":"crossref","unstructured":"Hosoi T, Koguchi Y, Sugikawa E, Chikada A, Ogawa K, Tsuda N, Suto N, Tsunoda S, Taniguchi T, and Ohnuki T (2002) Identification of a novel eicosanoid receptor coupled to Gi\/o. J Biol Chem 277: 31459\u201331465.","DOI":"10.1074\/jbc.M203194200"},{"key":"10.1124\/jpet.104.079079_bib18","doi-asserted-by":"crossref","unstructured":"Khanapure SP, Shi XX, Powell WS, and Rokach J (1998) Total synthesis of a potent proinflammatory 5-oxo-ETE and its 6,7-dihydro biotransformation product. J Org Chem 63: 337\u2013342.","DOI":"10.1021\/jo9716993"},{"key":"10.1124\/jpet.104.079079_bib19","doi-asserted-by":"crossref","unstructured":"Lawrence T, Willoughby DA, and Gilroy DW (2002) Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2: 787\u2013795.","DOI":"10.1038\/nri915"},{"key":"10.1124\/jpet.104.079079_bib20","doi-asserted-by":"crossref","unstructured":"Matsuoka T, Hirata M, Tanaka H, Takahashi Y, Murata T, Kabashima K, Sugimoto Y, Kobayashi T, Ushikubi F, Aze Y, et al. (2000) Prostaglandin D2 as a mediator of allergic asthma. Science (Wash DC) 287: 2013\u20132017.","DOI":"10.1126\/science.287.5460.2013"},{"key":"10.1124\/jpet.104.079079_bib21","doi-asserted-by":"crossref","unstructured":"Monneret G, Boumiza R, Gravel S, Cossette C, Bienvenu J, Rokach J, and Powell WS (2005) Effects of prostaglandin D2 and 5-lipoxygenase products on the expression of CD203c and CD11b by basophils. J Pharmacol Exp Ther 312: 627\u2013634.","DOI":"10.1124\/jpet.104.074823"},{"key":"10.1124\/jpet.104.079079_bib22","doi-asserted-by":"crossref","unstructured":"Monneret G, Cossette C, Gravel S, Rokach J, and Powell WS (2003) 15R-Methylprostaglandin D2 is a potent and selective CRTH2\/DP2 receptor agonist in human eosinophils. J Pharmacol Exp Ther 304: 349\u2013355.","DOI":"10.1124\/jpet.102.042937"},{"key":"10.1124\/jpet.104.079079_bib23","doi-asserted-by":"crossref","unstructured":"Monneret G, Gravel S, Diamond M, Rokach J, and Powell WS (2001) Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 98: 1942\u20131948.","DOI":"10.1182\/blood.V98.6.1942"},{"key":"10.1124\/jpet.104.079079_bib24","doi-asserted-by":"crossref","unstructured":"Monneret G, Li H, Vasilescu J, Rokach J, and Powell WS (2002) 15-Deoxy-\u039412,14-prostaglandins D2 and J2 are potent activators of human eosinophils. J Immunol 168: 3563\u20133569.","DOI":"10.4049\/jimmunol.168.7.3563"},{"key":"10.1124\/jpet.104.079079_bib25","doi-asserted-by":"crossref","unstructured":"Murray JJ, Tonnel AB, Brash AR, Roberts LJ, Gosset P, Workman R, Capron A, and Oates JA (1986) Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med 315: 800\u2013804.","DOI":"10.1056\/NEJM198609253151304"},{"key":"10.1124\/jpet.104.079079_bib26","doi-asserted-by":"crossref","unstructured":"Nagata K, Tanaka K, Ogawa K, Kemmotsu K, Imai T, Yoshie O, Abe H, Tada K, Nakamura M, Sugamura K, et al. (1999) Selective expression of a novel surface molecule by human Th2 cells in vivo. J Immunol 162: 1278\u20131286.","DOI":"10.4049\/jimmunol.162.3.1278"},{"key":"10.1124\/jpet.104.079079_bib27","doi-asserted-by":"crossref","unstructured":"Nantel F, Fong C, Lamontagne S, Wright DH, Giaid A, Desrosiers M, Metters KM, O\u2019Neill GP, and Gervais FG (2004) Expression of prostaglandin D synthase and the prostaglandin D2 receptors DP and CRTH2 in human nasal mucosa. Prostaglandins Other Lipid Mediat 73: 87\u2013101.","DOI":"10.1016\/j.prostaglandins.2003.12.002"},{"key":"10.1124\/jpet.104.079079_bib28","doi-asserted-by":"crossref","unstructured":"Powell WS (2003) 15-Deoxy-\u039412,14-PGJ2: endogenous PPAR\u03b3 ligand or minor eicosanoid degradation product? J Clin Investig 112: 828\u2013830.","DOI":"10.1172\/JCI200319796"},{"key":"10.1124\/jpet.104.079079_bib29","doi-asserted-by":"crossref","unstructured":"Powell WS, Chung D, and Gravel S (1995) 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration. J Immunol 154: 4123\u20134132.","DOI":"10.4049\/jimmunol.154.8.4123"},{"key":"10.1124\/jpet.104.079079_bib30","doi-asserted-by":"crossref","unstructured":"Shichijo M, Sugimoto H, Nagao K, Inbe H, Encinas JA, Takeshita K, Bacon KB, and Gantner F (2003) Chemoattractant receptor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto-prostaglandin D2-induced eosinophilia in rats. J Pharmacol Exp Ther 307: 518\u2013525.","DOI":"10.1124\/jpet.103.055442"},{"key":"10.1124\/jpet.104.079079_bib31","doi-asserted-by":"crossref","unstructured":"Shiraishi Y, Asano K, Nakajima T, Oguma T, Suzuki Y, Shiomi T, Sayama K, Niimi K, Wakaki M, Kagyo J, et al. (2005) Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor. J Pharmacol Exp Ther, in press.","DOI":"10.1016\/j.jaci.2004.12.203"},{"key":"10.1124\/jpet.104.079079_bib32","doi-asserted-by":"crossref","unstructured":"Stamatiou P, Hamid Q, Taha R, Yu W, Issekutz TB, Rokach J, Khanapure SP, and Powell WS (1998) 5-Oxo-ETE induces pulmonary eosinophilia in an integrin-dependent manner in Brown Norway rats. J Clin Investig 102: 2165\u20132172.","DOI":"10.1172\/JCI1995"},{"key":"10.1124\/jpet.104.079079_bib33","doi-asserted-by":"crossref","unstructured":"Straus DS and Glass CK (2001) Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev 21: 185\u2013210.","DOI":"10.1002\/med.1006.abs"},{"key":"10.1124\/jpet.104.079079_bib34","doi-asserted-by":"crossref","unstructured":"Tanaka K, Ogawa K, Sugamura K, Nakamura M, Takano S, and Nagata K (2000) Differential production of prostaglandin D2 by human helper T cell subsets. J Immunol 164: 2277\u20132280.","DOI":"10.4049\/jimmunol.164.5.2277"},{"key":"10.1124\/jpet.104.079079_bib35","doi-asserted-by":"crossref","unstructured":"Town MH, Casals-Stenzel J, and Schillinger E (1983) Pharmacological and cardiovascular properties of a hydantoin derivative, BW 245 C, with high affinity and selectivity for PGD2 receptors. Prostaglandins 25: 13\u201328.","DOI":"10.1016\/0090-6980(83)90131-4"},{"key":"10.1124\/jpet.104.079079_bib36","doi-asserted-by":"crossref","unstructured":"Urade Y and Hayaishi O (2000) Prostaglandin D synthase: structure and function. Vitam Horm 58: 89\u2013120.","DOI":"10.1016\/S0083-6729(00)58022-4"},{"key":"10.1124\/jpet.104.079079_bib37","doi-asserted-by":"crossref","unstructured":"Ward C, Dransfield I, Murray J, Farrow SN, Haslett C, and Rossi AG (2002) Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I\u03baB\u03b1 degradation using a peroxisome proliferator-activated receptor-\u03b3-independent mechanism. J Immunol 168: 6232\u20136243.","DOI":"10.4049\/jimmunol.168.12.6232"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524318907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524318907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.104.079079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:20:36Z","timestamp":1740000036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524318907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0022356524318907"],"URL":"https:\/\/doi.org\/10.1124\/jpet.104.079079","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Prostaglandin D2, 15-Deoxy-\u039412,14-prostaglandin J2, and Selective DP1 and DP2 Receptor Agonists on Pulmonary Infiltration of Eosinophils in Brown Norway Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.104.079079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}